ISIS 3: the last word on thrombolysis?
- 6 June 1992
- Vol. 304 (6840) , 1454-1455
- https://doi.org/10.1136/bmj.304.6840.1454
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.Heart, 1992
- Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.Heart, 1991
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Effects of posture on metabolic and hemodynamic predischarge exercise response after acute myocardial infarctionThe American Journal of Cardiology, 1990
- Antistreptokinase titres after intravenous streptokinaseThe Lancet, 1990
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988